Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000487976 | SCV000575092 | uncertain significance | not provided | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000487976 | SCV003021786 | benign | not provided | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004023230 | SCV004935616 | likely benign | Inborn genetic diseases | 2024-01-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004742448 | SCV005342780 | uncertain significance | RAI1-related disorder | 2024-05-24 | no assertion criteria provided | clinical testing | The RAI1 c.2329G>C variant is predicted to result in the amino acid substitution p.Asp777His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0058% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |